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Manuscript received February 12, 2014 and accepted May 5, 2014AbstractEvidence is sparse concerning hypertrophy of cardiomyocytes in left and right ventricles (LV, RV). LV and RV from
105 forensic autopsies were weighed. Cross sectioned cardiac myocyte thicknesses were measured in hematoxylin and
eosin–stained paraffin sections. Overweight (OW) is body weight >104.3 kg and hypertension (HT) is mean arterial
pressure >106.7 mm Hg assessed from renal histology. Mean RV weights and cardiomyocyte thicknesses held nearly perfect
proportionality to the LV values. Exceptions to these patterns were (1) myocytes were slightly thicker than expected in RVof
the 27 specimens with the smallest myocyte thicknesses; (2) weights were slightly greater than expected in RV of hyperten-
sives; and (3) myocytes were slightly smaller than expected in RVof OW subjects. Myocyte hypertrophy appears to affect LV
and RV equally, preserving constant proportionality between them in a number of conditions which include OW, HT, and
perhaps some cardiomyopathies. Ischemic, valvular, and right ventricular disorders determined at autopsy are specifically
omitted from this provisional conclusion. The three exceptions from this principle were of small magnitude and unimpressive
statistical significance which calls for cautious interpretation. Neither OW nor HT appears to act predictably upon the heart as
exclusively volume or pressure overload. J Am Soc Hypertens 2014;8(7):457–463.  2014 American Society of
Hypertension.
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Open access under CC BY-NC-ND license.Introduction
With mitral regurgitation, volume overload on the left
ventricle (LV) invokes eccentric hypertrophy; with aortic
stenosis, pressure overload invokes concentric hypertrophy.1
Those principles are sometimes extended to overweight
(OW) and hypertension (HT) under the assumption that
these conditions induce volume and pressure overloads,
respectively,2 with interactions in their effects still to be
pursued.3 Recent improvements in cardiac imaging have
raised doubts about these latter assumptions.3–5 Instances
of concentric and eccentric LV hypertrophy are often found
with both OW and HT.This work received no grant funding.
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Open access under CThe way that the right ventricle (RV) participates in these
events is controversial, and improved understanding of this
participation could help to clarify the complete picture. It is
often supposed that OW should produce excessive preload
with right ventricular hypertrophy (RVH) consequent to
reflexive pulmonary HT whereas essential HT ought often
not have these associations. In this regard, unexpected re-
sults from ongoing autopsy studies in this laboratory found
cardiac hypertrophy in HT and OW to affect LVs and RVs
equally, preserving a constant proportionality between
them, in keeping with other reports to that effect.6–9 To pur-
sue this lead, postmortem measurements of left and right
ventricular weights (LVW and RVW) were recorded in a
series of forensic autopsies to be reported here. As an addi-
tional source for confirmation or rejection of the results
from gross anatomy, cardiomyocyte sizes were measured
in histologic sections. This is done to help assure that
hypertrophy rather than physiological growth of ventricles
is under observation. The hypothesis under consideration
in the first step effort reported here is that, hypertrophy
may act alike on the LVs and RVs under conditions ofC BY-NC-ND license.
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offer guidance for further inquiry.
The linkage between RV and LV is complex and incom-
pletely understood. Well-recognized associations are that
the RV mass was usually found to correlate with LV mass
in OW6 and HT.7 However, the magnitudes of the relation-
ships were not pursued in those and other reports; pro-
portionality or linearity cannot be presumed. Suggested
mechanisms of such linkage include, among others, pulmo-
nary HT induced by LV diastolic dysfunction and hormonal
actions upon hypertrophy in both ventricles at once.8,9
Reports of correlations among the sizes of myocytes in
RV and LV are rare. Findings on enzymatically isolated LV
myocytes in suspension have described elliptic cylinders
which in the extremes display increased thickness with un-
changed length during concentric hypertrophy and normal
thickness with increased length in eccentric hypertrophy.10
How these concepts may apply to RV myocytes remains to
be ascertained. In normal adults aged 21–55 years, the my-
cocyte thicknesses on the right were reported as 82.6% of
those on the left.11 While cross-sectional area of right ven-
tricular myocytes in maturing rats were reported in ranges
of 83.9–93.0% of those on the left, myocyte lengths were
alike in the two ventricles.12 Myocyte lengths were reported
to increase in the right but not the LVs of exercised rats.13
The present report is an extension to the RV of previous
studies in this laboratory on LV myoctye dimensions.14–16
Of special interest is the relationship of RV to LV in this
series of forensic autopsies, excluding right ventricular
and valvular disorders because of excessively few cases
and instances of coronary heart disease, because of limited
resources to address the complexity of this challenge which
imposes heterogeneous hypertrophic responses to variously
affected parts of the ventricle. Ventricular hypertrophy is
expected for the most part to be the result of OW, HT, or
cardiomyopathy in this series, although distinctions among
these categories are less than ideal in the forensic setting.MethodsSubjectsDuring accessible days between November 2007 and
September 2012, the Orleans Parish Coroner’s Office sup-
plied 105 specimens. Of these, 73 cases had complete data
for evaluating effects of body weight (BW) and blood pres-
sure estimated from renal histology. All cases with cardio-
megaly (whole heart weight, >399 g in women and >449
g in men) were retained, other than those with right ventric-
ular, valvular, or ischemic disorders as determined at au-
topsy. Noncardiovascular cases without cardiomegaly were
chosen to have<12 hours postmortem intervals, no immedi-
ately preceding hospitalization, and cause of death unrelated
to cardiovascular disease. All analyses were done with the
entire pool of cases without subgrouping by cause of death.The complete set of 105 specimens was supplemented with
eight specimens selected for right ventricular defects (three
pulmonary embolus, three chronic bronchitis/emphysema,
one pulmonary fibrosis, and one arrhythmogenic right ven-
tricular dysplasia) yielding a total of 113 cases. Desirable
clinical information such as blood pressure levels or use of
medications was prohibitively hard to obtain, as is usual
for a forensic series. The institutional review board declared
this autopsy study exempt from their review.Left and Right Ventricular WeightAfter removing the epicardial fat, ventricles of the fresh
heart were divided from the atria, separated, and weighed.
The method of Bove et al17 was modified by using the fresh
rather than the formalin-fixed heart and by placing the
trabeculae carneae and papillary muscles from the right
side of the interventricular septum with the RV.Preparations for HistologyA slice of myocardium presenting the high chordal plane
was formalin fixed for one to three weeks. Samples were
excised perpendicular to this plane from lateral and poste-
rior LV walls and from two sites in the RV free wall.
Paraffin-embedded samples were sectioned at 6 mm and
stained with hematoxylin and eosin. To adjust for shrinkage
in paraffin sections, a factor of 1.21 was applied to sub-
sequent histologic measurements,14 although this is not
needed for the relative comparisons of myocyte thicknesses
in specimens reported here.Myocyte ProfilesMyocyte profiles in cross section were selected for
Figure 1 to represent average dimensions in left (A and C)
and right (B and D) ventricles in two cases falling near the
smallest (A and B) and largest (C and D) myocyte thick-
nesses. Profiles like these were evaluated by imposing an
ellipse upon each profile and measuring the minor axis of
the idealized outline, calling this the myocyte thickness
(MyL and MyR for left and right, respectively). These mea-
surements were made on black-and-white photographic
prints using a digital caliper accurate to 0.01 mm. Measure-
ments were taken in 60 anucleate profiles from LV sites
showing the best cross sectional profiles (four LV sites and
two RV sites in the first 78 cases and two sites from each
ventricle in the 35 subsequent cases).OverweightBW is the sum of lean plus fat masses with proxies
of height2.7 and body mass index (BMI, calculated by
weight/height2 [kg/m2]), respectively. It was found else-
where14 that MyL had multiple correlations with height2.7
and BMI that was indistinguishable from the correlation
Figure 1. Views of left (A and C) and
right (B and D) ventricles depict myo-
cytes of average dimensions in speci-
mens near the smallest (A and B) and
largest (C and D) myocyte thicknesses.
Hematoxylin and eosin, bars¼ 30 mm.
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to proxies for lean and fat masses in the relationship. Hence,
within this data set, BW is taken to be a better measure of
OW than is BMI for the limited purposes of this report con-
cerning cardiomyocyte sizes. OW is assigned when weight
>104.3 kg, the cutoff point found by logistic regression as
optimal for predicting left ventricular hypertrophy (LVH).HypertensionIntimal thickness of interlobular arteries in the renal cor-
tex was measured, and mean arterial pressure (MAP) was
calculated using a previously derived regression equation18
(MAP ¼ [S þ 2  D]/3). For the equation, the correlation
coefficient was r ¼ 0.702. Hence, r2 ¼ 49% of the variance
in clinically measured blood pressure is captured in the renal
histology. Although the calculated values will surely include
some false positives and false negatives, the averages within
groups were previously shown to predict sphygmomanom-
eter readings with acceptable precision. HT is assigned
when MAP >106.7 mm Hg (eg, 140 and 90 mm Hg).Left Ventricular HypertrophyLVH was considered present if LVW was >219 g in men
or >199 g in women. Among the 73 cases with complete
data, 36 were later classed as having LVH and 10 of those
received neither OW nor HT classification and may include
instances of false classification or perhaps cardiomyopathy
of uncertain types. Hypertrophic cardiomyopathy in the
usual sense of myocyte disarray was not encountered.
Statistical Methods
These are all commonly used techniques available in the
SAS programs (SAS Institute, Cary NC, 27512-8000).
Version 9.2 was used here.ResultsRVW According to LVWRVW increased stepwise with increasing range of LVW
(Figure 2, left). The slight decline with LVW in the ratio
RVW/LVW was not statistically significant by t test com-
parisons between groups (Figure 3, left). Black bars in
the figures depict findings in the eight supplemental sub-
jects added to the series to explore effects of right ventric-
ular disorders.MyR According to MyLMyR increased stepwise with increasing range of thick-
nesses in the LVs (MyL) (Figure 2, right). The ratio MyR/
MyL was unchanging with increases of MyL above 16.9 mm
(Figure 3, right). The 27 subjects with MyL <17 mm stood
out as showing the greatest mean ratios MyR/MyL.Adjustments for BW and MAPThe patterns seen in Figures 2 and 3 were also closely
reproduced in the subset of 73 cases with complete data
(Not Adj in Tables 1 and 2, t tests between groups became
weakly significant). The patterns were also little changed
after adjustments for BW and MAP determined from renal
histology (Adj in Tables 1 and 2).Relationships to OW and HTLarger values for RVWwere found to accompany both HT
and OW, but more clearly so for OW (P¼ .04 and P< .0001,
respectively in Table 3). The ratios of RVW/LVW were
almost constant, falling slightly lower for HT but not for
OW (P¼ .02 and .42, respectively in Table 3). Larger values
for MyR accompanied HT but not significantly so for
Figure 2. Means (95% confidence
intervals) of right ventricular features
grouped by left ventricular features.
Numbers of cases below the bars.
Black bars depict 8 cases with right
ventricular disorders. Columns failing
to share a symbol A, B, C, or D differ
significantly at P < .05 by t test.
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MyR/MyL were not significantly affected by the HT classi-
fication but were low in company with OW (P ¼ .39 and .04
respectively in Table 4). In the multiple regression of
MyR/MyL on BMI and height, the coefficient for BMI was
rejected (P ¼ .31) and the standardized equation was
MyR/MyL ¼ 0.27  height (R2 ¼ .07, P ¼ .019).Gender DifferencesAttempting to enter gender as a covariate in the analyses
of Figures 2 and 3 failed for lack of significance in all four
settings (P value ranged from .37 to .75). In the 73 cases with
complete data, the gender differences in LVW and RVW
failed to reach significance (‘Not Adj’ in Table 5, P ¼ .08
and .06, respectively), although only 14 women wereFigure 3. Means (95% confidence
intervals) of right ventricular features
grouped by left ventricular features.
Numbers of cases below the bars.
Black bars depict 8 cases with right
ventricular disorders. Columns failing
to share a symbol A or B differ signif-
icantly at P < .05 by t test.available. When adjusted for OW and HT, however, the
ventricles were significantly smaller in women (P ¼ .01
and .02 for LVW and RVW, respectively in Table 5).
The group of five men with both OW and HT displayed
exceptionally large mean LVWof 484 g (not shown). Omit-
ting this outlier group returned the gender differences to
insignificance (P¼ .09 for both LVWand RVW, not shown).
The ratios RVW/LVW and MyR/MyL lacked significance
in all comparisons between men and women (P ranged
from .42 to .76).
Discussion
The dominant finding in these results is a nearly perfect
proportionality between RVH and LVH. As the LVs
increased in size from one specimen to another, the RVs
Table 1
Means of selected variables according to LVW, adjusted and not adjusted









Interval Adj Not Adj Adj Not Adj
80–159 63.6A 50.6A 42.6B 40.8C 16
160–239 78.5B 78.4B 40.0B 40.0BC 32
240–319 85.7B 97.5C 34.6A 36.2ABC 12
320–610 153.2C 158.5D 34.6A 35.3A 13
Anova F P F P F P F P
LVW 41.8 <.0001 59.1 <.0001 3.4 .02 2.6 .06
BW 23.2 <.0001 3.9 .05
MAP 3.6 .06 0.5 .48
Adj, adjusted for BW and MAP; BW, body weight (Kg); LVW, left ven-
tricular weight; MAP, mean arterial pressure determined from renal histol-
ogy (mm Hg); RVW, right ventricular weight.
Means within a column that fail to share a symbol A, B, C, or D differ
significantly by t tests.
P < .05.
Table 3










No No 195.A 75.6A 39.2B 34
Yes No 265.B 107.1B 40.9B 14
No Yes 221.AB 82.2AB 38.0AB 18
Yes Yes 426.C 142.9C 33.3A 7
Anova F P F P F P
OW 27.7 <.0001 20.8 <.0001 0.7 .42
HT 12.7 .0007 4.4 .04 5.9 .02
Interactions 6.7 .01 2.1 .15 3.2 .08
HT, hypertension; LVW, left ventricular weight; OW, overweight; RVW,
right ventricular weight.
Means within a column that fail to share a symbol A, B, or C differ
significantly by t test.
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thickness. This constant proportionality is clear in the
nearly constant ratios RVW/LVW and MyR/MyL in group
comparisons.
A notable departure from the pattern of proportionality is
an excess in MyR among the 27 subjects with the smallest
LV myocytes. This departure has no ready explanation and
is open for speculation. Also lacking an explanation is the
slight lag in RVW seen in HT but not in OW (P ¼ .02 and
.42, respectively in Table 3). Another intriguing departure
from the pattern is a lag in RV myocyte thickening as the
LV hypertrophies in response to OW (P ¼ .04 for myocyte
ratios in Table 4), a finding that fails to emerge in hyperten-
sives (P ¼ .39). Retaining the proportion of right to left
ventricular sizes in HT would seem to confirm theTable 2
Means of selected variables according to MyL, adjusted and not adjusted









Interval Adj Not Adj Adj Not Adj
10.0–16.9 13.0A 12.9A 86.0B 86.2B 21
17.0–18.9 13.6A 13.6A 75.6A 75.5A 22
19.0–20.9 15.3B 15.3B 77.4A 77.2A 16
21.0–26.5 17.8C 17.9C 79.2AB 79.1A 14
Anova F P F P F P F P
MyL 18.4 <.0001 23.3 <.0001 4.2 .008 5.8 .001
BW 0.2 .63 0.7 .40
MAP 1.6 .21 1.2 .29
Adj, adjusted for BW and MAP; BW, body weight (Kg); MAP, mean
arterial pressure determined from renal histology (mm Hg); MyL, left ven-
tricular myocyte thickness; MyR, right ventricular myocyte thickness.
Means within a column that fail to share a symbol A, B, or C differ
significantly by t tests.
P < .05.expectation for pulmonary HT, given the commonplace
LV diastolic dysfunction in this condition.7 The outcome
with OW seems surprising in consideration of the frequent
finding of diastolic dysfunction in obese subjects.19 The
rejection of BMI while retaining height as a correlate of
MyR/MyL would seem to emphasize stature rather than
obesity in this surprising outcome. These departures are
of small magnitude and weak statistical significance; they
should perhaps call for cautious interpretation.
The set of 73 cases with complete data included only
14 women. Generally speaking, women differed little or
not at all from men in the relationships between RVs and
LVs, but this outcome is of limited value with so few cases.Importance and LimitationsOf possible importance in this study is the prospect of a
precise way to distinguish pulmonary from systemic causes
of RVH. This could be of value at postmortem examination,
and perhaps might offer insights for interpreting in vivo im-
ages when comparing right-left ventricular balance. The useTable 4










No No 17.4A 13.9A 80.7AB 34
Yes No 19.3B 14.5AB 74.7A 14
No Yes 18.7AB 15.4AB 82.3B 18
Yes Yes 20.9B 16.2B 77.6AB 7
Anova F P F P F P
OW 8.3 .005 1.0 .33 4.2 .04
HT 4.0 .05 5.3 .02 0.8 .39
Interactions 0.0 .89 0.0 .84 0.1 .81
HT, hypertension; MyL, left ventricular myocyte thickness; MyR, right
ventricular myocyte thickness; OW, overweight.
Means within a column that fail to share a symbol A, B, or C differ
significantly by t test.
Table 5
Means of selected variables according to gender adjusted and not adjusted for OW and HT in 73 cases with complete data
LVW (gm) RVW (gm) 100  (RVW/
LVW) (%)
MyL (mm) MyR (mm) 100  (MyR/
MyL) (%)
Not adjusted
Men (N ¼ 59) 248 94 38.8 18.6 14.7 79.3
Women (N ¼ 14) 189 71 38.1 17.4 14.1 81.0
Adjusted for OW and HT
Men (N ¼ 59) 291 107 37.9 19.4 15.1 78.5
Women (N ¼ 14) 221 81 37.7 18.0 14.4 80.0
Anova F P F P F P F P F P F P
Not adjusted
Gender 3.1 .08 3.7 .06 0.1 .73 2.1 .15 0.6 .45 0.4 .55
Adjusted for OW and HT
Gender 6.9 .01 6.0 .02 0.0 .95 2.0 .16 0.7 .42 0.1 .76
OW 18.6 <.0001 13.7 .0004 0.5 .47 7.6 .007 1.1 .29 2.9 .09
HT 6.6 .01 2.2 .15 2.5 .12 1.5 .22 2.3 .16 0.3 .59
HT, hypertension; LVW, left ventricular weight; MyL, left ventricular myocyte thickness; MyR, right ventricular myocyte thickness; OW, overweight;
RVW, right ventricular weight.
Means within a column that fail to share a symbol A or B differ significantly by t test.
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ventricular balance has received limited attention.4,6–9
This limitation may be due in part to the difficult methodol-
ogy of digitizing multiple cross sections through the RV so
as to sum the sequential measurements of chamber size and
wall mass.8 A possible importance for the finding of pre-
served proportionality between ventricles observed in this
series of forensic autopsies could be to help guide explora-
tions concerning the clinical significance of right ventricular
measurements. A detailed review of such clinical signifi-
cance is beyond the scope of this article. The limitations
of the data reported here are numerous and conspicuous,
and most of these are often shared with other past and pre-
sent efforts. Chief among these is the surprising difficulty
in measuring the dimensions of cardiomyocytes. Until a
gold standard becomes available, probes along these lines
must remain tentative. Also, the exclusion of ischemic,
valvular, and specifically right ventricular disorders leaves
serious gaps. Also needing confirmation or rejection is the
suggestion of equal importance for lean and fat body mass
in driving myocyte hypertrophy14 and cardiac output.20Provisional Conclusions
When LVs exceed 169 g, subsequent hypertrophy should
be expected to affect left and RVs equally, preserving a
constant proportionality between them. Ischemic, valvular,
and right ventricular disorders are specifically omitted from
this principle, which applies only to instances of OW, HT,
and perhaps some types of cardiomyopathy. Exceptions
from this principle are of uncertain importance because
they were of small magnitude and limited statistical signif-
icance. These findings could be of assistance forrecognizing unbalanced RVH that could point to underlying
pulmonary disorders.Acknowledgments
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